Mark D. Kent - 03 Jun 2026 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)

Reporting relationship: President - MSO
Issuer ticker: ALHC
Reported as of: 03 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Jun 2026, 16:20:50 UTC
Prior SEC filing: 02 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Christopher J. Joyce, as Attorney-in-Fact, for Mark D. Kent

Key filing fact

Mark D. Kent filed Form 4 for Alignment Healthcare, Inc. (ALHC) on 09 Jun 2026.

Key facts

This page summarizes Mark D. Kent's Form 4 filing for Alignment Healthcare, Inc. (ALHC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 09 Jun 2026, 16:20.

Change

Previous filing in this sequence was filed on 02 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001982370 Primary reporting owner

Kent Mark D.

Relationship: President - MSO
Address: 1100 W. TOWN & COUNTRY ROAD, SUITE 1600, ORANGE
Signature: /s/ Christopher J. Joyce, as Attorney-in-Fact, for Mark D. Kent
Signature date: 09 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALHC transaction

Common Stock

Award

Transaction value
Shares: +87,719
Change %: +591%
Price: $0.000000^*
Shares after: 102,567
Date: 03 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents 87,719 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of March 13, 2027, 2028 and 2029, subject to the reporting person's continued service to the Company as of the applicable vesting date.